Delivery Order SPE2DB24D2101-SPE2DB25FKFGG
Award Date
11/5/24
Potential Completion Date
11/27/24
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an award value of $79,904.76 and covers the delivery of ANDEXXA 200 MG VIALS, a specialty pharmaceutical product, through November 29, 2024. The contract is a firm-fixed-price type, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ANDEXXA 200 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price Delivery Order has a ceiling value of $13,317.46 and an ultimate completion date of August 5, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $79,161.66 firm fixed-price delivery order is for the supply of ANDEXXA 200 MG VIALS. The contract has an ultimate completion date of November 18, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of ANDEXXA 200 MG VIALS to the Defense Logistics Agency (DLA). The $16,783.10 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024 and was awarded on October 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award is for the delivery of ANDEXXA 200 MG VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $26,634.92, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a Firm Fixed Price arrangement, with a period of performance running through September 19, 2024. There were no set-aside requirements indicated for...
The U.S. federal government awarded a delivery order contract valued at $6,658.72 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of ANDEXXA 200 MG VIALS, a pharmaceutical product. This contract is not set aside for any particular business type. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,931.53, is for the delivery of ANDEXXA 200 MG VIALS and has an ultimate completion date of April 2, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, awarded by the Defense Logistics Agency (DLA), is for the delivery of ANDEXXA 200 MG VIALS, a pharmaceutical product, with a ceiling value of $8,391.55. The contract has a period of performance through July 12, 2024 and utilizes a firm fixed-price pricing type. Amerisourcebergen holds a larger...
This federal contract award, valued at $14,801.16, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a for-profit pharmaceutical distribution company. The contract is for the supply of ANDEXXA 200 MG VIALS, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen Drug Corporation and DLA, valued at up to $999,999,999.00 and running through December 31, 2025....
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,165.40 firm-fixed-price contract is for the supply of medical and pharmaceutical products to support federal healthcare programs and facilities. The award is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support...